Drug recall · November 9, 2016
Ramipril Capsules recall
Why: Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.
- Lots / codes
Lot #: 1136091A, Incorrectly Labeled Exp: 03/18
- Quantity
- 15,984 bottles
- Company
- Actavis Laboratories, FL, Inc., Davie, FL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- August 30, 2016 · Voluntary: Firm initiated
- Classified
- November 1, 2016
- Reported
- November 9, 2016
- Ended
- November 6, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ramipril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.